English
简体中文
Total: £ 56.28
2024-11-25 | Pages: 99 | Tables: 202
Human diploid cell rabies vaccine is produced by human cell matrix, which has the advantages of good immune response, fast onset, good safety, and longer duration of immunity The global market for Human Diploid Cell Rabies Vaccine was estimated to be...
2024-11-25 | Pages: 162 | Tables: 284
The global market for Non-Sterile Liquids and Suspension was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Non-St...
2024-11-25 | Pages: 126 | Tables: 232
The global market for Digestive Capsules was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Digestive Capsules was...
2024-11-25 | Pages: 92 | Tables: 215
A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paedi...
2024-11-25 | Pages: 166 | Tables: 293
Anti-angiogenic ophthalmic agents act as antagonists against the vascular endothelial growth factor (VEGF). When retinal pigment cells become ischemic and dry up VEGF stimulates generation of new blood vessels by a process called neovascularization. ...
2024-11-25 | Pages: 167 | Tables: 270
Anti-angiogenic ophthalmic agents act as antagonists against the vascular endothelial growth factor (VEGF). When retinal pigment cells become ischemic and dry up VEGF stimulates generation of new blood vessels by a process called neovascularization. ...
2024-11-25 | Pages: 131 | Tables: 206
Giant cell arteritis (GCA) is a granulomatous medium and large-vessel vasculitis. It is the most common form of systemic vasculitis, with an incidence of between 15 and 25 cases per 100,000 persons over 50 years of age. The global market for Giant Ce...
2024-11-25 | Pages: 145 | Tables: 248
Calcineurin is a cellular enzyme that catalyzes some processes in activated T-lymphocytes. Calcineurin inhibitors are primarily used as immunosuppressive drugs and inhibit the key signaling phosphatase Calcineurin. This activity makes these drugs as ...
2024-11-25 | Pages: 93 | Tables: 206
Steroid hormones, also known as steroid hormones, are a class of tetracyclic aliphatic hydrocarbon compounds with cyclopentane polyhydrophenanthrene nuclei. Steroid hormones are steroids that act as hormones. These include sex hormones for the gonads...
2024-11-25 | Pages: 119 | Tables: 249
Coccidiosis is a parasitic disease of a wide variety of animals caused by coccidian protozoa. The disease spreads from one animal to another by contact with infected feces or ingestion of infected tissue. Diarrhea is the primary symptom of Coccidiosi...
2024-11-25 | Pages: 123 | Tables: 211
The global market for OTC Painkillers was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion US...
2024-11-25 | Pages: 107 | Tables: 201
The global market for Medicinal Marijuana was estimated to be worth US$ 6500 million in 2023 and is forecast to a readjusted size of US$ 9299.6 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030 North American market for Medicin...
2024-11-25 | Pages: 128 | Tables: 241
The global market for Pruritus Ani Medicine was estimated to be worth US$ 850 million in 2023 and is forecast to a readjusted size of US$ 1179.1 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030 North American market for Prurit...
2024-11-25 | Pages: 127 | Tables: 240
The global market for Pruritus Type Skin Diseases Medicine was estimated to be worth US$ 5100 million in 2023 and is forecast to a readjusted size of US$ 6771.8 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030 North American m...
2024-11-25 | Pages: 161 | Tables: 273
The global market for Liver Health Capsule was estimated to be worth US$ 8200 million in 2023 and is forecast to a readjusted size of US$ 11260 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030 North American market for Liver H...
